Department of General Practice, Faculty of Medicine, Nantes University, 1, rue Gaston Veil, 44035, Nantes, France.
Department of General Practice, Faculty of Medicine, Nantes University, 1, rue Gaston Veil, 44035, Nantes, France; University Research Department, Nantes University Hospital, Nantes, France.
Breast. 2024 Feb;73:103613. doi: 10.1016/j.breast.2023.103613. Epub 2023 Nov 25.
and purpose: In France, women lack information to make a shared decision to start breast cancer screening. Decision aids are useful to facilitate this discussion, yet few meet international standards. The objective of this project was to build, validate and measure the quality of a decision aid for organized breast screening in France, in line with international standards, intended for both women and healthcare professionals.
This mixed-methods study was conducted between January 2017 and June 2022. The prototype was developed from a qualitative study, systematic review and targeted literature review and alpha tested during two Delphi rounds. Readability was evaluated with the Flesch score and content with International Patient Decision Aid Standards Instrument (IPSASi).
An online decision aid, accessible at www.Discutons-mammo.fr, written in French was developed. The content included eligibility, information about breast screening the advantages and disadvantages of screening, patient preferences and a patient-based discussion guide using text, infographics, and videos. The Flesch readability test score was 65.4 and the IPDASi construct quality score was 176 out of 188.
This decision aid complies with IPDASi standards and could help women eligible for breast screening in France make a shared decision with a specialized healthcare professional about whether or not to participate in organized breast screening.
在法国,女性缺乏做出共同决策以开始乳腺癌筛查的信息。决策辅助工具对于促进这一讨论很有用,但符合国际标准的工具很少。该项目的目的是根据国际标准,为法国有组织的乳腺癌筛查构建、验证和衡量一种决策辅助工具的质量,供女性和医疗保健专业人员使用。
这是一项混合方法研究,于 2017 年 1 月至 2022 年 6 月进行。该原型是从定性研究、系统评价和有针对性的文献综述中开发的,并在两轮德尔菲法中进行了阿尔法测试。可读性用 Flesch 评分评估,内容用国际患者决策辅助标准工具(IPDASi)评估。
开发了一个在线决策辅助工具,可在 www.Discutons-mammo.fr 上访问,用法语编写。内容包括资格、关于乳房筛查的信息、筛查的优缺点、患者偏好以及使用文本、信息图表和视频的基于患者的讨论指南。Flesch 可读性测试得分为 65.4,IPDASi 结构质量得分为 176 分(满分 188 分)。
该决策辅助工具符合 IPDASi 标准,可帮助有资格接受法国乳腺癌筛查的女性与专业医疗保健人员共同决定是否参加有组织的乳腺癌筛查。